Oligometastatic Non-Small-Cell Lung Cancer: How Should We Define and Manage It?
- PMID: 29324207
- PMCID: PMC5765903
- DOI: 10.1200/JOP.2017.028290
Oligometastatic Non-Small-Cell Lung Cancer: How Should We Define and Manage It?
Comment on
-
Managing Patients With Oligometastatic Non-Small-Cell Lung Cancer.J Oncol Pract. 2018 Jan;14(1):23-31. doi: 10.1200/JOP.2017.026500. J Oncol Pract. 2018. PMID: 29324212
References
-
- Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med. 2009;361:32–39. - PubMed
-
- Rusthoven KE, Hammerman SF, Kavanagh BD, et al. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Acta Oncol. 2009;48:578–583. - PubMed
-
- Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009;9:302–312. - PubMed
-
- Norton L, Simon R. Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep. 1977;61:1307–1317. - PubMed
-
- Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 1979;63:1727–1733. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
